23948sdkhjf
  1. Udbud
  2. Laboratorieudstyr, optisk- og præcisionsudstyr
  3. Instrumenter til kontrol af fysiske karakteristika

Fakta om udbudet

EU-nr
2020/S 084-198925
Offentliggjort
29.04.2020
Udbudstype
Udbud med forhandling uden forudgående offentliggørelse

Udbyder

University of Copenhagen

Vindere

(29.04.2020)
Evosep Biosystems
Thriges Plads 6
5000 Odense C

Acquisition of three Evosep One Instruments to Proteomics Research Infrastructure

University of Copenhagen

Voluntary ex ante transparency notice

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority/entity

I.1) Name and addresses
Official name: University of Copenhagen
Postal address: Nørregade 10
Town: Copenhagen K
NUTS code: DK01
Postal code: 1165
Country: Denmark
Contact person: Mahmut Yüksel
E-mail: Fgn253@ku.dk

Internet address(es):

Main address: www.KU.dk

I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Education

Section II: Object

II.1) Scope of the procurement
II.1.1) Title:

Acquisition of three Evosep One Instruments to Proteomics Research Infrastructure

II.1.2) Main CPV code
38432200
II.1.3) Type of contract
Supplies
II.1.4) Short description:

The procurement is a purchase of a new and unique equipment related to establishing a Proteomics Research Infrastructure (PRI) at the University of Copenhagen.

II.1.6) Information about lots
This contract is divided into lots: no
II.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: 2 403 040.31 DKK
II.2) Description
II.2.1) Title:
II.2.2) Additional CPV code(s)
II.2.3) Place of performance
NUTS code: DK
II.2.4) Description of the procurement:

The procurement is a purchase of a new and unique equipment related to establishing a Proteomics Research Infrastructure (PRI) at the University of Copenhagen. The procurement will be used for to support research and development across the University of Copenhagen. As the support will be based upon existing technologies at CPR, the PRI will have to be equipped with same methodologies and technologies as available at CPR in order to be able to provide same type of analytical support.

II.2.5) Award criteria
II.2.11) Information about options
Options: no
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information

Section IV: Procedure

IV.1) Description
IV.1.1) Type of procedure
Negotiated procedure without prior publication
  • The works, supplies or services can be provided only by a particular economic operator for the following reason:
    • absence of competition for technical reasons
Explanation:

No other supplier is able to provide analytical LC equipment with similar specifications for high-throughput, low-flow and sensitive analysis of complex peptide samples as an integrated LC-MS solution. The unique features of the relevant equipment are:

Use of disposable trap columns:

• reduces carry-over in e.g. complex HeLa digests to < 0.05 % of TIC;

• reduces cycle time (<5min per sample).

Partial elution from trap columns.

• leaves impurities on the disposable traps, thereby greatly increasing column life.

Gradient offset focusing (where the organic %B-gradient is lowered concurrently with the elution and pre-separation of peptides in a pre-formed gradient).

• allows shorter columns / improves resolving power on analytical column.

Fast trap-elution and gradient formation at 30μl/min.

Use of a long and narrow storage loop as hand-over between the low-pressure, high-flow gradient preparation and the high-pressure, low-flow gradient delivery.

Optimized high-throughput capabilities:

• up to 300 samples/day @ 1-2 μl/min flow rate;

• up to 93 % MS utilization rate.

Only Evosep Bioscience can provide an integrated solution that allows high-throughput of complex peptide samples (up to 300 samples/day) and ensures high utilization rate of the MS instrumentation (up to 93 %)

The services offered by the PRI will be based upon the technological developments established at CPR. Thus in order to provide this, the equipment purchased for the PRI needs to be similar to the one available at CPR.

IV.1.3) Information about framework agreement
IV.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure

Section V: Award of contract/concession

V.2) Award of contract/concession
V.2.1) Date of contract award decision:
03/04/2020
V.2.2) Information about tenders
The contract has been awarded to a group of economic operators: no
V.2.3) Name and address of the contractor/concessionaire
Official name: Evosep Biosystems
Postal address: Thriges Plads 6
Town: Odense C
NUTS code: DK031
Postal code: 5000
Country: Denmark
E-mail: info@evosep.com
Telephone: +45 26332021

Internet address: http://www.evosep.com

The contractor/concessionaire will be an SME: no
V.2.4) Information on value of the contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: 2 403 040.31 DKK
V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information:
VI.4) Procedures for review
VI.4.1) Review body
Official name: Danish Public Contracts Appeal Board
Postal address: Nævnenes hus, toldboden 2
Town: Viborg
Postal code: 8800
Country: Denmark
E-mail: NH@naevneneshus.dk
Telephone: +45 72405600

Internet address: www.KLFU.dk

VI.4.2) Body responsible for mediation procedures
VI.4.3) Review procedure
VI.4.4) Service from which information about the review procedure may be obtained
VI.5) Date of dispatch of this notice:
27/04/2020

Send til en kollega

0.081